These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22037188)

  • 1. The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.
    Wadosky KM; Willis MS
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H515-26. PubMed ID: 22037188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Regulation of PPARs through Post-Translational Modifications.
    Brunmeir R; Xu F
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR SUMOylation: some useful experimental tips.
    Pourcet B; Staels B; Glineur C
    Methods Mol Biol; 2013; 952():145-61. PubMed ID: 23100230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARs and Myocardial Infarction.
    Wagner KD; Wagner N
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.
    Youssef J; Badr M
    Br J Pharmacol; 2011 Sep; 164(1):68-82. PubMed ID: 21449912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice.
    Wang Y; Nakajima T; Gonzalez FJ; Tanaka N
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and role of peroxisome proliferator-activated receptors in the porcine early placenta trophoblast.
    Blitek A; Szymanska M
    Domest Anim Endocrinol; 2019 Apr; 67():42-53. PubMed ID: 30690257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of PTEN ubiquitylation and SUMOylation using molecular traps.
    Lang V; Aillet F; Da Silva-Ferrada E; Xolalpa W; Zabaleta L; Rivas C; Rodriguez MS
    Methods; 2015 May; 77-78():112-8. PubMed ID: 25224693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation.
    Shimizu M; Yamashita D; Yamaguchi T; Hirose F; Osumi T
    Mol Cell Biochem; 2006 Jun; 286(1-2):33-42. PubMed ID: 16534556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
    Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
    Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of peroxisome proliferator-activated receptors (PPAR) in immune responses.
    Christofides A; Konstantinidou E; Jani C; Boussiotis VA
    Metabolism; 2021 Jan; 114():154338. PubMed ID: 32791172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes.
    Holdsworth-Carson SJ; Permezel M; Riley C; Rice GE; Lappas M
    Placenta; 2009 Feb; 30(2):176-86. PubMed ID: 19070893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
    Ohshima T; Koga H; Shimotohno K
    J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of peroxisome proliferator-activated receptor-alpha by MDM2.
    Gopinathan L; Hannon DB; Peters JM; Vanden Heuvel JP
    Toxicol Sci; 2009 Mar; 108(1):48-58. PubMed ID: 19103650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.
    Cui W; Sun M; Galeva N; Williams TD; Azuma Y; Staudinger JL
    Drug Metab Dispos; 2015 Sep; 43(9):1316-25. PubMed ID: 26063058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
    Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights in Post-Translational Modifications: Ubiquitin and SUMO.
    Salas-Lloret D; González-Prieto R
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.